This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Leukaemia
  • /
  • Gilteritinib for the treatment of relapsed and/or ...
Journal

Gilteritinib for the treatment of relapsed and/or refractory FLT3-mutated acute myeloid leukemia.

Read time: 1 mins
Published:1st Sep 2019
Author: McMahon CM, Perl AE.
Availability: Pay for access, or by subscription
Ref.:Expert Rev Clin Pharmacol. 2019;12(9):841-849.
DOI:10.1080/17512433.2019.1657009
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest